United States Cancer Vaccines Market Report 2017

October 2017 | 108 pages | ID: UFB35357530EN
QYResearch

Abstracts

In this report, the United States Cancer Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Cancer Vaccines in these regions, from 2012 to 2022 (forecast).

United States Cancer Vaccines market competition by top manufacturers/players, with Cancer Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Dendreon
• GlaxoSmithKline
• Merck
• Sanofi
• Amgen
• Biothera
• Isa Pharmaceuticals
• Bristol-Myers Squibb
• Bavarian Nordic
• Antigen Express
• Juvaris Biotherapeutics
• Provectus Biopharmaceuticals
• Aduro BioTech
• Galena Biopharma
• Northwest Biotherapeutics
• Oxford BioMedica
• Inovio Pharmaceuticals
• Vaxon Biotech
• Celldex Therapeutics
• Prima BioMed

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Rophylactic Vaccines
• Therapeutic Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Adults
• Children

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Cancer Vaccines Market Report 2017

1 CANCER VACCINES OVERVIEW

1.1 Product Overview and Scope of Cancer Vaccines
1.2 Classification of Cancer Vaccines by Product Category
  1.2.1 United States Cancer Vaccines Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Cancer Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Rophylactic Vaccines
  1.2.4 Therapeutic Vaccines
1.3 United States Cancer Vaccines Market by Application/End Users
  1.3.1 United States Cancer Vaccines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Adults
  1.3.3 Children
1.4 United States Cancer Vaccines Market by Region
  1.4.1 United States Cancer Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Cancer Vaccines Status and Prospect (2012-2022)
  1.4.3 Southwest Cancer Vaccines Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Cancer Vaccines Status and Prospect (2012-2022)
  1.4.5 New England Cancer Vaccines Status and Prospect (2012-2022)
  1.4.6 The South Cancer Vaccines Status and Prospect (2012-2022)
  1.4.7 The Midwest Cancer Vaccines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Cancer Vaccines (2012-2022)
  1.5.1 United States Cancer Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 United States Cancer Vaccines Revenue and Growth Rate (2012-2022)

2 UNITED STATES CANCER VACCINES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Cancer Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Cancer Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Cancer Vaccines Average Price by Players/Suppliers (2012-2017)
2.4 United States Cancer Vaccines Market Competitive Situation and Trends
  2.4.1 United States Cancer Vaccines Market Concentration Rate
  2.4.2 United States Cancer Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Cancer Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CANCER VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Cancer Vaccines Sales and Market Share by Region (2012-2017)
3.2 United States Cancer Vaccines Revenue and Market Share by Region (2012-2017)
3.3 United States Cancer Vaccines Price by Region (2012-2017)

4 UNITED STATES CANCER VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Cancer Vaccines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Cancer Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States Cancer Vaccines Price by Type (2012-2017)
4.4 United States Cancer Vaccines Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CANCER VACCINES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Cancer Vaccines Sales and Market Share by Application (2012-2017)
5.2 United States Cancer Vaccines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CANCER VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Dendreon
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Cancer Vaccines Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Dendreon Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline
  6.2.2 Cancer Vaccines Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GlaxoSmithKline Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merck
  6.3.2 Cancer Vaccines Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sanofi
  6.4.2 Cancer Vaccines Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanofi Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Amgen
  6.5.2 Cancer Vaccines Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Amgen Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Biothera
  6.6.2 Cancer Vaccines Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Biothera Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Isa Pharmaceuticals
  6.7.2 Cancer Vaccines Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Isa Pharmaceuticals Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bristol-Myers Squibb
  6.8.2 Cancer Vaccines Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bristol-Myers Squibb Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Bavarian Nordic
  6.9.2 Cancer Vaccines Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Bavarian Nordic Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Antigen Express
  6.10.2 Cancer Vaccines Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Antigen Express Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Juvaris Biotherapeutics
6.12 Provectus Biopharmaceuticals
6.13 Aduro BioTech
6.14 Galena Biopharma
6.15 Northwest Biotherapeutics
6.16 Oxford BioMedica
6.17 Inovio Pharmaceuticals
6.18 Vaxon Biotech
6.19 Celldex Therapeutics
6.20 Prima BioMed

7 CANCER VACCINES MANUFACTURING COST ANALYSIS

7.1 Cancer Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cancer Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cancer Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cancer Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CANCER VACCINES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Cancer Vaccines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Cancer Vaccines Sales Volume Forecast by Type (2017-2022)
11.3 United States Cancer Vaccines Sales Volume Forecast by Application (2017-2022)
11.4 United States Cancer Vaccines Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Cancer Vaccines
Figure United States Cancer Vaccines Market Size (K Units) by Type (2012-2022)
Figure United States Cancer Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Rophylactic Vaccines Product Picture
Figure Therapeutic Vaccines Product Picture
Figure United States Cancer Vaccines Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Cancer Vaccines by Application in 2016
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Children Examples
Table Key Downstream Customer in Children
Figure United States Cancer Vaccines Market Size (Million USD) by Region (2012-2022)
Figure The West Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cancer Vaccines Sales (K Units) and Growth Rate (2012-2022)
Figure United States Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cancer Vaccines Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Cancer Vaccines Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Cancer Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cancer Vaccines Sales Share by Players/Suppliers
Figure 2017 United States Cancer Vaccines Sales Share by Players/Suppliers
Figure United States Cancer Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Cancer Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Cancer Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cancer Vaccines Revenue Share by Players/Suppliers
Figure 2017 United States Cancer Vaccines Revenue Share by Players/Suppliers
Table United States Market Cancer Vaccines Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Cancer Vaccines Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Cancer Vaccines Market Share of Top 3 Players/Suppliers
Figure United States Cancer Vaccines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Cancer Vaccines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Cancer Vaccines Product Category
Table United States Cancer Vaccines Sales (K Units) by Region (2012-2017)
Table United States Cancer Vaccines Sales Share by Region (2012-2017)
Figure United States Cancer Vaccines Sales Share by Region (2012-2017)
Figure United States Cancer Vaccines Sales Market Share by Region in 2016
Table United States Cancer Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Cancer Vaccines Revenue Share by Region (2012-2017)
Figure United States Cancer Vaccines Revenue Market Share by Region (2012-2017)
Figure United States Cancer Vaccines Revenue Market Share by Region in 2016
Table United States Cancer Vaccines Price (USD/Unit) by Region (2012-2017)
Table United States Cancer Vaccines Sales (K Units) by Type (2012-2017)
Table United States Cancer Vaccines Sales Share by Type (2012-2017)
Figure United States Cancer Vaccines Sales Share by Type (2012-2017)
Figure United States Cancer Vaccines Sales Market Share by Type in 2016
Table United States Cancer Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Cancer Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Vaccines by Type (2012-2017)
Figure Revenue Market Share of Cancer Vaccines by Type in 2016
Table United States Cancer Vaccines Price (USD/Unit) by Types (2012-2017)
Figure United States Cancer Vaccines Sales Growth Rate by Type (2012-2017)
Table United States Cancer Vaccines Sales (K Units) by Application (2012-2017)
Table United States Cancer Vaccines Sales Market Share by Application (2012-2017)
Figure United States Cancer Vaccines Sales Market Share by Application (2012-2017)
Figure United States Cancer Vaccines Sales Market Share by Application in 2016
Table United States Cancer Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Cancer Vaccines Sales Growth Rate by Application (2012-2017)
Table Dendreon Basic Information List
Table Dendreon Cancer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dendreon Cancer Vaccines Sales Growth Rate (2012-2017)
Figure Dendreon Cancer Vaccines Sales Market Share in United States (2012-2017)
Figure Dendreon Cancer Vaccines Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Cancer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Cancer Vaccines Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Cancer Vaccines Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Cancer Vaccines Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Cancer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Cancer Vaccines Sales Growth Rate (2012-2017)
Figure Merck Cancer Vaccines Sales Market Share in United States (2012-2017)
Figure Merck Cancer Vaccines Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Cancer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Cancer Vaccines Sales Growth Rate (2012-2017)
Figure Sanofi Cancer Vaccines Sales Market Share in United States (2012-2017)
Figure Sanofi Cancer Vaccines Revenue Market Share in United States (2012-2017)
Table Amgen Basic Information List
Table Amgen Cancer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Cancer Vaccines Sales Growth Rate (2012-2017)
Figure Amgen Cancer Vaccines Sales Market Share in United States (2012-2017)
Figure Amgen Cancer Vaccines Revenue Market Share in United States (2012-2017)
Table Biothera Basic Information List
Table Biothera Cancer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biothera Cancer Vaccines Sales Growth Rate (2012-2017)
Figure Biothera Cancer Vaccines Sales Market Share in United States (2012-2017)
Figure Biothera Cancer Vaccines Revenue Market Share in United States (2012-2017)
Table Isa Pharmaceuticals Basic Information List
Table Isa Pharmaceuticals Cancer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Isa Pharmaceuticals Cancer Vaccines Sales Growth Rate (2012-2017)
Figure Isa Pharmaceuticals Cancer Vaccines Sales Market Share in United States (2012-2017)
Figure Isa Pharmaceuticals Cancer Vaccines Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Cancer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Cancer Vaccines Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Cancer Vaccines Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Cancer Vaccines Revenue Market Share in United States (2012-2017)
Table Bavarian Nordic Basic Information List
Table Bavarian Nordic Cancer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bavarian Nordic Cancer Vaccines Sales Growth Rate (2012-2017)
Figure Bavarian Nordic Cancer Vaccines Sales Market Share in United States (2012-2017)
Figure Bavarian Nordic Cancer Vaccines Revenue Market Share in United States (2012-2017)
Table Antigen Express Basic Information List
Table Antigen Express Cancer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Antigen Express Cancer Vaccines Sales Growth Rate (2012-2017)
Figure Antigen Express Cancer Vaccines Sales Market Share in United States (2012-2017)
Figure Antigen Express Cancer Vaccines Revenue Market Share in United States (2012-2017)
Table Juvaris Biotherapeutics Basic Information List
Table Provectus Biopharmaceuticals Basic Information List
Table Aduro BioTech Basic Information List
Table Galena Biopharma Basic Information List
Table Northwest Biotherapeutics Basic Information List
Table Oxford BioMedica Basic Information List
Table Inovio Pharmaceuticals Basic Information List
Table Vaxon Biotech Basic Information List
Table Celldex Therapeutics Basic Information List
Table Prima BioMed Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Vaccines
Figure Manufacturing Process Analysis of Cancer Vaccines
Figure Cancer Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Cancer Vaccines Major Players/Suppliers in 2016
Table Major Buyers of Cancer Vaccines
Table Distributors/Traders List
Figure United States Cancer Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Cancer Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Cancer Vaccines Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Cancer Vaccines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Cancer Vaccines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Cancer Vaccines Sales Volume (K Units) Forecast by Type in 2022
Table United States Cancer Vaccines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Cancer Vaccines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Cancer Vaccines Sales Volume (K Units) Forecast by Application in 2022
Table United States Cancer Vaccines Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Cancer Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cancer Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cancer Vaccines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources